Found: 12
Select item for more details and to access through your institution.
A Phase Ib Dose Escalation Trial of RO4929097 (a γ-secretase inhibitor) in Combination with Exemestane in Patients with ER + Metastatic Breast Cancer (MBC).
- Published in:
- 2022
- By:
- Publication type:
- journal article
Protein kinase C α enhances migration of breast cancer cells through FOXC2-mediated repression of p120-catenin.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Efferocytosis produces a prometastatic landscape during postpartum mammary gland involution.
- Published in:
- Journal of Clinical Investigation, 2014, v. 124, n. 11, p. 4737, doi. 10.1172/JCI76375
- By:
- Publication type:
- Article
Phase 1 study of TTC-352 in patients with metastatic breast cancer progressing on endocrine and CDK4/6 inhibitor therapy.
- Published in:
- Breast Cancer Research & Treatment, 2020, v. 183, n. 3, p. 617, doi. 10.1007/s10549-020-05787-z
- By:
- Publication type:
- Article
G1T48, an oral selective estrogen receptor degrader, and the CDK4/6 inhibitor lerociclib inhibit tumor growth in animal models of endocrine-resistant breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2020, v. 180, n. 3, p. 635, doi. 10.1007/s10549-020-05575-9
- By:
- Publication type:
- Article
Extranuclear ERα is associated with regression of T47D PKCα-overexpressing, tamoxifen-resistant breast cancer.
- Published in:
- Molecular Cancer, 2013, v. 12, n. 1, p. 1, doi. 10.1186/1476-4598-12-34
- By:
- Publication type:
- Article
Identification of novel RARß2 transcript variants with short 5'-UTRs in normal and cancerous breast epithelial cells.
- Published in:
- Oncogene, 2005, v. 24, n. 7, p. 1296, doi. 10.1038/sj.onc.1208284
- By:
- Publication type:
- Article
Revisiting Estrogen for the Treatment of Endocrine-Resistant Breast Cancer: Novel Therapeutic Approaches.
- Published in:
- Cancers, 2023, v. 15, n. 14, p. 3647, doi. 10.3390/cancers15143647
- By:
- Publication type:
- Article
Endocrine Therapy-Resistant Breast Cancer Cells Are More Sensitive to Ceramide Kinase Inhibition and Elevated Ceramide Levels Than Therapy-Sensitive Breast Cancer Cells.
- Published in:
- Cancers, 2022, v. 14, n. 10, p. 2380, doi. 10.3390/cancers14102380
- By:
- Publication type:
- Article
Design of an ideal hormone replacement therapy for women.
- Published in:
- Molecular Carcinogenesis, 1996, v. 17, n. 3, p. 108, doi. 10.1002/(SICI)1098-2744(199611)17:3<108::AID-MC1>3.0.CO;2-B
- By:
- Publication type:
- Article
PKCα and ERβ Are Associated with Triple-Negative Breast Cancers in African American and Caucasian Patients.
- Published in:
- International Journal of Breast Cancer, 2012, p. 1, doi. 10.1155/2012/740353
- By:
- Publication type:
- Article
Exploring DNA methylation changes in promoter, intragenic, and intergenic regions as early and late events in breast cancer formation.
- Published in:
- 2015
- By:
- Publication type:
- journal article